Dare Bioscience, Inc. - stock earnings
DARE Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q3 | -8.3 million USD | 1.0 million USD |
2023Q2 | -8.8 million USD | ? USD |
2023Q1 | -7.7 million USD | ? USD |
2022Q4 | 421.7 million USD | 10.0 billion USD |
2022Q3 | -6.9 million USD | ? USD |
2022Q2 | 413998 USD | 10.0 million USD |
2022Q1 | -8.4 million USD | ? USD |
2021Q4 | -9.5 million USD | ? USD |
2021Q3 | -12.7 million USD | ? USD |
2021Q2 | -9.2 million USD | ? USD |
2021Q1 | -7.3 million USD | ? USD |
2020Q4 | -8.4 million USD | ? USD |
2020Q3 | -7.6 million USD | ? USD |
2020Q2 | -7.1 million USD | ? USD |
2020Q1 | -4.3 million USD | ? USD |
2019Q4 | -3.9 million USD | ? USD |
2019Q3 | -3.4 million USD | ? USD |
2019Q2 | -4.0 million USD | ? USD |
2019Q1 | -2.9 million USD | ? USD |
2018Q4 | -2.9 million USD | ? USD |
2018Q3 | -2.6 million USD | ? USD |
2018Q2 | -3.6 million USD | ? USD |
2018Q1 | -7.7 million USD | ? USD |
2017Q4 | -9.1 million USD | -1.8 million USD |
2017Q3 | -1.6 million USD | 2.5 million USD |
2017Q2 | -4.1 million USD | 642000 USD |
2017Q1 | -6.3 million USD | 1.2 million USD |
2016Q4 | -4.9 million USD | 766000 USD |
2016Q3 | -10.0 million USD | ? USD |
2016Q2 | -10.9 million USD | ? USD |
2016Q1 | -13.5 million USD | ? USD |
2015Q4 | -10.7 million USD | ? USD |
2015Q3 | -10.6 million USD | ? USD |
2015Q2 | -9.9 million USD | ? USD |
2015Q1 | -8.4 million USD | ? USD |
2014Q4 | -7.5 million USD | 80000 USD |
2014Q3 | -5.6 million USD | 1.6 million USD |
2014Q2 | -7.4 million USD | 33000 USD |
2014Q1 | -2.9 million USD | 47000 USD |
2013Q4 | -3.5 million USD | 6000 USD |
2013Q3 | -3.2 million USD | ? USD |
2013Q2 | -4.9 million USD | ? USD |
2013Q1 | -5.6 million USD | ? USD |
DARE Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -41.0 million USD | 1.0 million USD |
2022 | 406.8 million USD | 10.0 million USD |
2021 | -38.3 million USD | 10.0 million USD |
2020 | -27.4 million USD | ? USD |
2019 | -14.3 million USD | ? USD |
2018 | -27.0 million USD | ? USD |
2017 | -11.5 million USD | ? USD |
2016 | -39.3 million USD | 766000 USD |
2015 | -39.6 million USD | ? USD |
2014 | -23.3 million USD | 80000 USD |
2013 | -17.1 million USD | 6000 USD |
2012 | -22.1 million USD | 625000 USD |
DARE
Price: $0.31
52 week price:
Earnings Per Share: -0.35 USD
P/E Ratio: -0.74
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 165200
Ebitda: -1.3 millionMarket Capitalization: 48.3 million